Transforaminal epidural injection versus continued conservative care in acute sciatica (TEIAS trial): study protocol...

Area of Science:

• Pain Management
• Neurology
• Clinical Trials

Background:

• Sciatica, characterized by leg pain from herniated lumbar discs, often requires conservative treatment.
• Intractable sciatica pain impedes patients, with no clear consensus on optimal acute-phase management.
• The TEIAS trial investigates novel treatments for severe sciatica.

Purpose of the Study:

• To assess the effectiveness of transforaminal epidural injection (TEI) for sciatica.
• To evaluate the cost-effectiveness of TEI compared to standard pain medication.
• To determine the predictive capability of TEI on patient outcomes in acute sciatica.

Main Methods:

• A prospective, open-label, randomized controlled trial involving 142 patients.
• Patients randomized to either TEI (lidocaine with steroids) or standard oral pain medication.
• Primary outcome: leg pain score at 2 weeks; secondary outcomes include functionality and cost-effectiveness.

Main Results:

• The study aims to compare the effectiveness of TEI against standard pain medication for sciatica.
• Data collection includes pain, functionality, and cost-effectiveness over 21 weeks.
• Results will inform decision-making for acute sciatica treatment.

Conclusions:

• Effective conservative treatments for acute sciatica, especially severe cases, are needed.
• TEI shows potential for improving outcomes in sciatica patients.
• This research will aid in optimizing sciatica management strategies.